Integrated Field Vaccination and Laboratory Challenge Reveal Immune Gene Responses and Protective Efficacy in Asian Seabass ( Lates calcarifer ) Following Oral Administration of an Inactivated Vibrio harveyi Vaccine
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Aquaculture Research
- Vol. 2026 (1)
Abstract
Vibriosis, caused by Vibrio spp ., poses a significant challenge in marine aquaculture, leading to severe economic losses. Vaccination has emerged as a safer and more effective alternative to antibiotics for disease control, with oral vaccination offering advantages such as ease of administration and scalability for large‐scale aquaculture operations. This study evaluated the efficacy of an oral inactivated Vibrio harveyi vaccine in a field environment with cage‐cultured Asian seabass ( Lates calcarifer ) at Pulau Ketam, Klang, Selangor, Malaysia. Fish were divided into two groups: (1) a vaccinated group fed a commercial diet supplemented with formalin‐killed V. harveyi (10 8 CFU/mL) and palm oil as an adjuvant and (2) a placebo control group fed a commercial diet supplemented with phosphate‐buffered saline (PBS) and palm oil adjuvant. The vaccine was administered orally at weeks 0, 2, and 6 for three consecutive days at a dosage of 4% of the fish’s body weight. Immune‐related gene expression, including dendritic cells (DCs), complement factor 3 (C3), chemokine ligand 4 (CCL4), tumor necrosis factor‐α (TNF‐α), and immunoglobulin‐T (IgT), was significantly upregulated ( p < 0.05) in vaccinated fish compared to controls, with peak expression observed following booster doses. At week 10, a laboratory challenge trial with V. harveyi (1 × 10 8 CFU/mL) demonstrated an 80% relative percentage survival (RPS) in the vaccinated group, whereas the unvaccinated group exhibited 100% mortality. In addition, vaccinated fish displayed reduced clinical signs following infection. These findings highlight the potential of oral inactivated V. harveyi vaccines to induce robust immune responses and confer effective protection against vibriosis in Asian seabass. This approach provides a practical and scalable solution for disease management in marine aquaculture, improving health outcomes and productivity for fish farmers.Keywords
Funding Information
- Ministry of Higher Education, Malaysia
This publication has 49 references indexed in Scilit:
- A QTL associated with vibriosis resistance highlights the significant role of jam2a gene in tongue sole (Cynoglossus semilaevis)Aquaculture, 2024
- Pathology and pathogenesis of Vibrio infection in fish: A reviewAquaculture Reports, 2022
- Vibrio harveyi protease deletion mutant as a live attenuated vaccine candidate against vibriosis and transcriptome profiling following vaccination for Epinephelus fuscoguttatusAquaculture International, 2018
- Characterisation of ZBTB46 and DC-SCRIPT/ZNF366 in rainbow trout, transcription factors potentially involved in dendritic cell maturation and activation in fishDevelopmental & Comparative Immunology, 2018
- A formalin-inactivated vaccine provides good protection against Vibrio harveyi infection in orange-spotted grouper ( Epinephelus coioides )Fish & Shellfish Immunology, 2017
- GapA, a potential vaccine candidate antigen against Streptococcus agalactiae in Nile tilapia ( Oreochromis niloticus )Fish & Shellfish Immunology, 2017
- Efficacy of α-enolase-based DNA vaccine against pathogenic Streptococcus iniae in Nile tilapia ( Oreochromis niloticus )Aquaculture, 2017
- Booster immersion vaccination using diluted Yersinia ruckeri bacterin confers protection against ERM in rainbow troutAquaculture, 2015
- Expression profile of immune-related genes in Lates calcarifer infected by Cryptocaryon irritansFish & Shellfish Immunology, 2013
- The use of fish vaccines in the Chilean salmon industry 1999-2003Aquaculture, 2007